Skip to content Skip to search

Republish This Story

* Please read before republishing *

We’re happy to make this story available to republish for free under an Attribution-NonCommercial-NoDerivatives Creative Commons license as long as you follow our republishing guidelines, which require that you credit The 19th and retain our pixel. See our full guidelines for more information.

To republish, simply copy the HTML at right, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to The 19th. Have questions? Please email [email protected].

— The Editors

Loading...

Modal Gallery

/
Donate to our newsroom

Menu

Topics

  • Abortion
  • Politics
  • Education
  • LGBTQ+
  • Caregiving
  • Environment & Climate
  • Business & Economy
View all topics

The 19th News(letter)

News that represents you, in your inbox every weekday.

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting...

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

This email address might not be capable of receiving emails (according to Bouncer). You should try again with a different email address. If you have any questions, contact us at [email protected].

  • Latest Stories
  • Our Mission
  • Our Team
  • Ways to Give
  • Search
  • Contact
Donate
Home

We’re an independent, nonprofit newsroom reporting on gender, politics and policy. Read our story.

Topics

  • Abortion
  • Politics
  • Education
  • LGBTQ+
  • Caregiving
  • Environment & Climate
  • Business & Economy
View all topics

The 19th News(letter)

News that represents you, in your inbox every weekday.

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting...

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

This email address might not be capable of receiving emails (according to Bouncer). You should try again with a different email address. If you have any questions, contact us at [email protected].

  • Latest Stories
  • Our Mission
  • Our Team
  • Ways to Give
  • Search
  • Contact

We’re an independent, nonprofit newsroom reporting on gender, politics and policy. Read our story.

The 19th News(letter)

News that represents you, in your inbox every weekday.

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting...

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

This email address might not be capable of receiving emails (according to Bouncer). You should try again with a different email address. If you have any questions, contact us at [email protected].

Become a member

The 19th thanks our sponsors. Become one.

Health

How Medicare drug price negotiations stand to impact women

Women make up more than half of Medicare recipients and are more likely to skip or delay taking their medications due to cost. 

An Opened Prescription Medicine Bottle Among Many Other Sealed Bottles on Yellow Background.
Over half of Medicare recipients are women, and an even higher proportion rely on Medicare for their medication coverage. (Getty Images)

Sara Luterman

Disability and Aging Reporter

Published

2023-08-30 09:17
9:17
August 30, 2023
am

Republish this story

Share

  • Bluesky
  • Facebook
  • Email

Republish this story

We’re answering the “how” and “why” of health news. Sign up for our daily newsletter.

Women, in particular, stand to benefit from a Biden administration initiative allowing Medicare to negotiate the prices for medications for the first time, experts say. 

The program created under the Inflation Reduction Act aims to reduce the cost of some of the most expensive medications under Medicare, with the first 10 announced this week. Over half of Medicare recipients are women, and an even higher proportion rely on Medicare for their medication coverage. Women are also more likely to skip or delay taking medication due to cost.

The 19th thanks our sponsors. Become one.

“Women typically have lower pay and less wealth, which makes it harder for them to afford care,” said Leigh Purvis, prescription drug principal for the AARP Foundation. The AARP Foundation advocates on behalf of older Americans.  “They are more likely to skip those medications. There’s just a lot of factors that make women potentially more susceptible to those high prescription drug prices. And that’s what makes this change so important for them.” 

Women aged 65 and older also tend to have less flexibility in their budgets if their medication prices increase, said Stacie Dusetzina, a professor of health policy at Vanderbilt Medical Center. 

The selected drugs account for $50.5 billion in Medicare Part D drug costs, according to the Department of Health and Human Services, or about 20 percent of total prescription costs for the program. The drugs were selected based on highest Medicare spending, how long they have been on the market and whether they currently face competition from rivals. The move is currently being fought by the drug industry in court. 

  • More health coverage
    Image of an Opill pill package
  • The first over-the-counter birth control pill has been approved by the FDA. What will it cost?
  • How the loss of Medicaid dental coverage is impacting pregnant and postpartum people
  • For years, Republican states wouldn’t pass diaper laws. The end of abortion protections changed that.

“From our perspective, we think this was a huge success. Prior to now, Medicare was not able to negotiate drug prices on behalf of its tens of millions of beneficiaries,” Purvis told The 19th. “We think that Medicare is going to bring a lot of bargaining clout to the table, and that is going to result in lower drug prices, which, of course, is something that our members have been asking for for a very long time.”

Drug price negotiation is largely popular. According to polling from nonpartisan health policy research group KFF from last year, 89 percent of Democrats and 77 percent of Republicans support the federal government negotiating some drug prices for people with Medicare.

Some of the drugs on the list are commonly prescribed, like Elquis, a blood thinner used to treat heart failure. Elquis costs $4,000 per year on average for Medicare enrollees who take it. Other drugs, like Imbruvica, a cancer drug, are less commonly prescribed but even more costly. Average total spending for a Medicare enrollee taking Imbruvica is over $120,000. 

Two on the list, Stelara and Enbrel, will also particularly benefit women when it becomes lower cost. Both medications treat autoimmune conditions like Crohn’s disease and rheumatoid arthritis, and nearly 80 percent of patients diagnosed with autoimmune disease are women. 

Now that the list of drugs is public, pharmaceutical companies have until October 1 to declare whether they will participate in price negotiation or not. If they opt out, they will either need to pay a large excise tax or pull all of their products from Medicare and Medicaid. Both moves would take a large bite out of their profits. 

Consumers will not feel the result of this move for some time. The Centers for Medicare and Medicaid Services (CMS) will publish the negotiated prices on September 1, 2024, but those prices will not go into effect until January 1, 2026. In a news release, CMS announced it will select up to 15 more drugs for 2027, up to 15 more drugs for 2028 and up to 20 more drugs each year after that, in accordance with the Inflation Reduction Act. 

Other Inflation Reduction Act provisions like a $35 cap on out-of-pocket payments for insulin and a $2,000 cap for prescription drugs taken at home will be felt much sooner and take effect in 2025. 

It is unclear whether this move will impact drug prices for people who are not on Medicare — something experts including Purvis will be watching closely.  

“There are some states who are already working on this legislation that would tie the prices that they pay to the prices that are negotiated by Medicare Part D. So there’s a very real chance that people will use the Medicare negotiated prices as the new threshold for when they start negotiating prices for themselves,” she said. 

Republish this story

Share

  • Bluesky
  • Facebook
  • Email

Recommended for you

Image of an Opill pill package
The first over-the-counter birth control pill has been approved by the FDA. What will it cost?
A mother holds her sleeping baby.
There’s a new pill for postpartum depression, but who can access it?
Harris’ Medicare proposal could transform long-term care for the middle class
Women and Health Care Illustration
The 19th Explains: Trump and Biden’s health care plans through a gender lens

The 19th News(letter)

News that represents you, in your inbox every weekday.

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting...

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

This email address might not be capable of receiving emails (according to Bouncer). You should try again with a different email address. If you have any questions, contact us at [email protected].

Become a member

Explore more coverage from The 19th
Abortion Politics Education LGBTQ+ Caregiving
View all topics

Our newsroom's Spring Member Drive is here!

Learn more about membership.

  • Transparency
    • About
    • Team
    • Contact
    • Privacy Policy
    • Community Guidelines
  • Newsroom
    • Latest Stories
    • 19th News Network
    • Podcast
    • Events
    • Careers
    • Fellowships
  • Newsletters
    • Daily
    • Weekly
    • The Amendment
    • Event Invites
  • Support
    • Ways to Give
    • Sponsorship
    • Republishing
    • Volunteer

The 19th is a reader-supported nonprofit news organization. Our stories are free to republish with these guidelines.